Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

FDA Warns Against Using Smartwatches For Blood Glucose Monitoring

FDA warns consumers about potential health risks of using smartwatches for blood glucose monitoring. Stay informed for accurate diabetes management.

Top News

FDA approves 1st-of-its-kind treatment for severe food allergies

The FDA has approved the first drug that can reduce the severity of multiple food allergies at once.

LiveScience

Supreme Court Denies Red State Effort to Intervene in Mifepristone Case

The Court also rejects a late-filed amicus briefs from the American Bar Association, but accepts one from former FDA Commissioners.

Reason

From analysis to the latest developments in health,
read the most diverse news in one place.

1st frostbite drug approved by FDA after successful clinical trial

A drug called Aurlumyn has been approved to treat severe frostbite in the U.S. after a successful clinical trial.

LiveScience

Elon Musk's Neuralink has concerning lack of transparency and could be vulnerable to hacking, ethicists warn

Brain-computer interfaces have the potential to transform some people's lives, but they raise a host of ethical issues, too.

LiveScience

FDA Approves First Drug To Treat Food Allergies: Here's What You Need To Know

Xolair, a medication initially designed for asthma, has been approved for treating food allergies to prevent severe reactions.

Medical Daily

FDA approves a drug to treat severe food allergies, including milk, eggs and nuts

Xolair is considered the first medication approved by the FDA that can help protect against severe allergic reactions brought on by accidental exposure to certain foods.

WEKU

Read news from The Economist, FT, and more,
with one subscription

The CDC investigates a multistate E. coli outbreak linked to raw cheddar cheese

Health officials reported 10 cases of E. coli infection, adding that the number of people sick is likely "much higher." Those cases were from California, Colorado, Texas and Utah.

WEKU

FDA approves first cell therapy to treat aggressive forms of melanoma

Amtagvi is intended to help patients with melanoma that cannot be removed with surgery or has spread to other parts of the body.

WEKU

Pharma Stocks Analysis: Grab, Hold, or Sell?

Despite economic pressures and intensified competition, government incentives and drug innovations are fueling growth in the pharma sector. So, let us delve into the analysis of leading pharma stocks Bristol-Myers Squibb (BMY), Collegium Pharmaceutical (COLL), Pfizer (PFE), and Vaxcyte (PCVX), assessing whether to Grab, Hold, or Sell the stocks amid…

StockNews.com

FDA approves first-ever drug to treat severe frostbite and "prevent lifechanging amputation of fingers or toes"

Frostbite is an injury to the skin caused when the skin and its underlying tissues freeze, preventing blood, oxygen and nutrients from reaching the affected areas

Advnture

Mailed Abortion Pills Found To Be Safe Ahead Of US Ruling

Abortions administered as pills sent in the mail are just as safe and effective as those provided in person, a US study said Thursday ahead of a Supreme Court ruling on restricting the medication.

International Business Times

Abortion pills that patients got via telehealth and the mail are safe, study finds

The study looks at 6,000 patients who got abortion pills after an online appointment. It found that 99.7% of those abortions were not followed by any serious adverse events.

WEKU

Telehealth abortions are as safe and effective as in-person, large study shows

An analysis of more than 6,000 telehealth abortion recipients in the U.S. suggests that receiving the abortion drugs via a virtual doctor's appointment is as safe and effective as doing so in person.

LiveScience

Get all your
news in one place.

100’s of premium titles.
One news app.

Top News

US FDA Approves First Treatment for Severe Frostbite

The US FDA has approved the first-ever treatment for severe frostbite, a breakthrough for victims of this debilitating condition.

Barchart

1 Pharma Stock to Buy Near 52-Week Highs

GSK's stock has been a poor performer for years. But recently, the pharma stock keeps setting new 52-week highs, thanks to its blockbuster vaccines.

Top News

FDA approves new chemotherapy treatment for pancreatic cancer patients

Learn about the FDA-approved chemotherapy treatment for pancreatic cancer that offers hope to patients, with insights from experts and real-life survivor s...

This device gives you a full health check up in a minute, and it's smaller than a smartphone

The Withings BeamO can be used by up to 8 users in the same household

Get all your
news in one place.

100’s of premium titles.
One news app.

Top News

FDA Warns Online Vendors Selling Misbranded Weight-Loss and Diabetes Drugs

The FDA issues warnings to online vendors selling misbranded weight-loss and diabetes drugs, highlighting potential health risks and illegal practices.

Top News

Samsung Galaxy Watch receives FDA authorization for Sleep Apnea Feature

Samsung's sleep apnea feature on the Galaxy Watch has received FDA authorization, allowing users to detect signs of sleep apnea and seek medical care.

Barchart

It's Not Too Late to Buy Eli Lilly Stock. Here's Why.

J.P. Morgan thinks sales of weight-loss drugs could exceed $100 billion by 2030. That's good news for Eli Lilly, which is now the largest pharma company by market capitalization and the 9th-biggest S&P 500 stock. Here's why LLY stock looks poised to put on even more weight in the months…

Android Central

Galaxy Watch to detect signs of sleep apnea as the FDA gives the all-clear

Samsung's Galaxy Watch will be able to detect signs of sleep apnea in the U.S. as the FDA gives its approval.

StockNews.com

Why Investors Are Flocking to These 2 Medical Stocks

Given the growing demand for healthcare facilities, rapid integration of digital technology, and transformative biotechnology breakthroughs, the medical industry is poised for continued growth and profitability this year and beyond. Amid this, let’s find out why investors are flocking to medical stocks Vertex Pharmaceuticals (VRTX) and McKesson (MCK). Read more….

WEKU

Research at the heart of a federal case against the abortion pill has been retracted

A research paper that raises questions about the safety of abortion has been retracted. The research is cited in a federal judge's ruling about the abortion pill mifepristone.

Investors Business Daily

How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month

Cytokinetics has shucked off two high-profile setbacks, leading CYTK stock to double as it looks to take on Bristol in heart disease.

1 … 32 33 34 35

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.